Cannabis for Pain Relief (CanSex Trial)

"At present, 31 trials exploring the potential of Active Cannabis are underway with 3 in their final Phase. The majority are based out of Hartford, Connecticut but span across 46 sites globally."

"This clinical trial is recruiting 160 individuals between the ages of 21 and 55 who suffer from chronic pain. In addition to this, prospective participants must meet a few other criteria: females in the trial must be cycling regularly; male or non-pregnant female aged between 21-55 years old; no prior treatment for cannabis use; light users with no reported negative side effects while smoking cannabis; BMI ranging 18.5 - 34kg/m2.; and lastly, all women are required to practice an effective form of birth control that does not involve hormones."

"Accumulated research on Active Cannabis has been conducted in a total of 32 cities, across 5 countries. This research began with the Jazz Pharmaceutical-sponsored study that involved 200 patients and completed its Phase 2 & 3 drug approval stage in 2015. Since then, an additional 60 trials have been performed to further examine this medication's efficacy."

"Affirmative. Clinicaltrials.gov lists this clinical trial as being open for recruitment since its initial posting on June 30th 2021, with the last update occurring October 9th 2022. The study is currently searching for 160 participants from one medical site."

"Active Cannabis received a rating of 1, as this is an early-stage trial and the existing evidence regarding safety and efficacy is still limited."

"On the condition that applicants are aged 21 to 55, this trial will accept their inclusion. In addition, 162 studies have been conducted for people under 18 and 555 studies focus on patients over 65 years old."

"Indeed, clinicaltrials.gov displays that this trial is looking for participants; the initial posting was on June 30th 2021 and the most recent update occurred on October 9th 2022."